2023 Speakers

Allison Webb

Medical Affairs Operations Project Manager

Blueprint Medicines

Anne Cropp

Chief Scientific Officer

Early Access Care

Annie Drelles

Director & Head of Office of Medical Access, Global Oncology & Medical Affairs

Daiichi Sankyo

Annmarie Galli

Head of Global Medical Affairs Research, Compassionate Use & Managed Access Programs Oncology

GlaxoSmithKline

Ashling Dion

Manager, Clinical Trial Mgmt GMA Oncology

Daiichi Sankyo, Inc.

Bethany Bearden

Senior Manager - Medical Affairs Operations & Project

Blueprint Medicines

Blake Morrison

Global Medical Affairs Executive

Caligor Coghlan representative

Christine Istanboulian

Operations & Efficiency Lead - Managed Access & Humanitarian Programs

Sanofi Genzyme

Clinigen Representative

Dorian Readnour

Executive Director, Global Patient Access

Sarepta Therapeutics

Eva Gallagher

Vice President & Head of Medical Affairs, Senior Director, Medical Science Liaison Field Team Medical Affairs

Agios

Jeff Waldron

Executive Director

Sherborn Consulting

Kjersten Teeter

Director & Head Of Medical Affairs Operations

Blueprint Medicines

Liliana Alfaya

Medical Affairs and Strategic Collaborations Executive

Machelle Manuel

VP Medical Affairs

Amylyx Pharmaceuticals Corp.

Mario Aguiar

Director - Global Medical Affairs & Rare Diseases

Sanofi Genzyme

Merideth Rodgers

Global Director - Medical Affairs, Hematology & Rare Disease

Regeneron Pharmaceuticals Inc

Michelle Clausen

Senior Director - Expanded Access & Enterprise Medical Community

Pfizer

myTomorrows representative

Omar Rahman

Associate Director - Expanded Access Program

Argenx

Rachel Harrison

Associate Director - Early Access Program

Apellis Pharmaceuticals

Stephanie Smith

Early/Expanded Access & Registry Program Lead

Agios Pharmaceuticals

Taylor Schreiner

Project Manager

Bionical Emas

Tiffany Kawai

Director, Program Management and Operational Excellence, Global Oncology Medical Affairs

Daiichi Sankyo, Inc.